The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Notch pathway inhibition with LY3039478 in adenoid cystic carcinoma (ACC).
 
Caroline Even
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Innate Pharma; Merck Serono
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Merck Serono
 
Ulrik Niels Lassen
No Relationships to Disclose
 
Jaime R. Merchan
Consulting or Advisory Role - Exelixis
Research Funding - Agensys; Lilly; Novartis; Rexahn Pharmaceuticals; Tocagen; TRACON Pharma
 
Christophe Le Tourneau
Honoraria - Bristol-Myers Squibb; Novartis
Consulting or Advisory Role - Debiopharm Group; GamaMabs Pharma
Travel, Accommodations, Expenses - Merck Serono; MSD
 
Jean-Charles Soria
Honoraria - Astex Pharmaceuticals; AstraZeneca; GamaMabs Pharma; GlaxoSmithKline; Lilly; Merus; MSD; Pfizer; PharmaMar; Pierre Fabre; Roche; Sanofi; SERVIER; Symphony Evolution; Takeda
 
Charles Ferte
Travel, Accommodations, Expenses - Amgen; Genentech; GlaxoSmithKline; MedImmune
 
Jon Thomas Diener
Employment - Lilly
 
Eunice Yuen
Employment - Lilly
 
Claire Smith
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Gerard Joseph Oakley
Employment - Lilly
Stock and Other Ownership Interests - Lilly
Research Funding - Lilly
Patents, Royalties, Other Intellectual Property - Lilly; NanoBio Tek
 
Karim A. Benhadji
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Christophe Massard
Consulting or Advisory Role - Lilly